Domino's Valuation Crisis Explained | Business and Finance News

Domino’s stock is hitting rock bottom—trading at just 20.1x earnings, a 33% plunge from its decade-long average. Investors are panicking over two big threats: the rise of GLP-1 weight-loss drugs and slowing foot traffic. U.S. same-store sales barely budged in Q1 (up 0.9%) and Q2 (up 0.1%), while international sales dipped when adjusted for currency. With millions projected to be on these drugs by 2030—and already cutting back on sugar and processed foods—it’s clear pizza’s golden era may be fading. Domino’s CEO says no direct impact yet, but Wall Street is betting on the future. Is this low valuation a sign of trouble—or just a fair price for a company facing a new reality? Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/1d7d184e5d830d7c